Table of Contents 1 Study Coverage 1.1 Molecular Diagnostics in Cancer Testing Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Molecular Diagnostics in Cancer Testing Market Size Growth Rate by Product 1.4.2 Type I 1.4.3 Type II 1.5 Market by End User 1.5.1 Global Molecular Diagnostics in Cancer Testing Market Size Growth Rate by End User 1.5.2 Application 1 1.5.3 Application 2 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Molecular Diagnostics in Cancer Testing Market Size 2.1.1 Global Molecular Diagnostics in Cancer Testing Revenue 2014-2025 2.1.2 Global Molecular Diagnostics in Cancer Testing Sales 2014-2025 2.2 Molecular Diagnostics in Cancer Testing Growth Rate by Regions 2.2.1 Global Molecular Diagnostics in Cancer Testing Sales by Regions 2.2.2 Global Molecular Diagnostics in Cancer Testing Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Molecular Diagnostics in Cancer Testing Sales by Manufacturers 3.1.1 Molecular Diagnostics in Cancer Testing Sales by Manufacturers 3.1.2 Molecular Diagnostics in Cancer Testing Sales Market Share by Manufacturers 3.1.3 Global Molecular Diagnostics in Cancer Testing Market Concentration Ratio (CR5 and HHI) 3.2 Molecular Diagnostics in Cancer Testing Revenue by Manufacturers 3.2.1 Molecular Diagnostics in Cancer Testing Revenue by Manufacturers (2014-2019) 3.2.2 Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2014-2019) 3.3 Molecular Diagnostics in Cancer Testing Price by Manufacturers 3.4 Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution, Product Types 3.4.1 Molecular Diagnostics in Cancer Testing Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Molecular Diagnostics in Cancer Testing Product Type 3.4.3 Date of International Manufacturers Enter into Molecular Diagnostics in Cancer Testing Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Molecular Diagnostics in Cancer Testing Sales by Product 4.2 Global Molecular Diagnostics in Cancer Testing Revenue by Product 4.3 Molecular Diagnostics in Cancer Testing Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Molecular Diagnostics in Cancer Testing Breakdown Data by End User 6 North America 6.1 North America Molecular Diagnostics in Cancer Testing by Countries 6.1.1 North America Molecular Diagnostics in Cancer Testing Sales by Countries 6.1.2 North America Molecular Diagnostics in Cancer Testing Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Molecular Diagnostics in Cancer Testing by Product 6.3 North America Molecular Diagnostics in Cancer Testing by End User 7 Europe 7.1 Europe Molecular Diagnostics in Cancer Testing by Countries 7.1.1 Europe Molecular Diagnostics in Cancer Testing Sales by Countries 7.1.2 Europe Molecular Diagnostics in Cancer Testing Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Molecular Diagnostics in Cancer Testing by Product 7.3 Europe Molecular Diagnostics in Cancer Testing by End User 8 Asia Pacific 8.1 Asia Pacific Molecular Diagnostics in Cancer Testing by Countries 8.1.1 Asia Pacific Molecular Diagnostics in Cancer Testing Sales by Countries 8.1.2 Asia Pacific Molecular Diagnostics in Cancer Testing Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Molecular Diagnostics in Cancer Testing by Product 8.3 Asia Pacific Molecular Diagnostics in Cancer Testing by End User 9 Central & South America 9.1 Central & South America Molecular Diagnostics in Cancer Testing by Countries 9.1.1 Central & South America Molecular Diagnostics in Cancer Testing Sales by Countries 9.1.2 Central & South America Molecular Diagnostics in Cancer Testing Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Molecular Diagnostics in Cancer Testing by Product 9.3 Central & South America Molecular Diagnostics in Cancer Testing by End User 10 Middle East and Africa 10.1 Middle East and Africa Molecular Diagnostics in Cancer Testing by Countries 10.1.1 Middle East and Africa Molecular Diagnostics in Cancer Testing Sales by Countries 10.1.2 Middle East and Africa Molecular Diagnostics in Cancer Testing Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Molecular Diagnostics in Cancer Testing by Product 10.3 Middle East and Africa Molecular Diagnostics in Cancer Testing by End User 11 Company Profiles 11.1 Abbott Molecular Diagnostics 11.1.1 Abbott Molecular Diagnostics Company Details 11.1.2 Company Business Overview 11.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Products Offered 11.1.5 Abbott Molecular Diagnostics Recent Development 11.2 Accugenomics 11.2.1 Accugenomics Company Details 11.2.2 Company Business Overview 11.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Accugenomics Molecular Diagnostics in Cancer Testing Products Offered 11.2.5 Accugenomics Recent Development 11.3 Agendia 11.3.1 Agendia Company Details 11.3.2 Company Business Overview 11.3.Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Agendia Molecular Diagnostics in Cancer Testing Products Offered 11.3.5 Agendia Recent Development 11.4 Ambry Genetics 11.4.1 Ambry Genetics Company Details 11.4.2 Company Business Overview 11.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Ambry Genetics Molecular Diagnostics in Cancer Testing Products Offered 11.4.5 Ambry Genetics Recent Development 11.5 Biodesix 11.5.1 Biodesix Company Details 11.5.2 Company Business Overview 11.5.3 Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Biodesix Molecular Diagnostics in Cancer Testing Products Offered 11.5.5 Biodesix Recent Development 11.6 bioMerieux 11.6.1 bioMerieux Company Details 11.6.2 Company Business Overview 11.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.6.4 bioMerieux Molecular Diagnostics in Cancer Testing Products Offered 11.6.5 bioMerieux Recent Development 11.7 bioTheranostics (AviaraDx) 11.7.1 bioTheranostics (AviaraDx) Company Details 11.7.2 Company Business Overview 11.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.7.4 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Products Offered 11.7.5 bioTheranostics (AviaraDx) Recent Development 11.8 Cancer Genetics 11.8.1 Cancer Genetics Company Details 11.8.2 Company Business Overview 11.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Cancer Genetics Molecular Diagnostics in Cancer Testing Products Offered 11.8.5 Cancer Genetics Recent Development 11.9 Clarient, Inc. (GE Healthcare) 11.9.1 Clarient, Inc. (GE Healthcare) Company Details 11.9.2 Company Business Overview 11.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Products Offered 11.9.5 Clarient, Inc. (GE Healthcare) Recent Development 11.10 Counsyl 11.10.1 Counsyl Company Details 11.10.2 Company Business Overview 11.10.3 Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Counsyl Molecular Diagnostics in Cancer Testing Products Offered 11.10.5 Counsyl Recent Development 11.11 Flatiron Health 11.12 Epigenomics 11.13 Exact Sciences Corporation 11.14 Exiqon 11.15 Genomic Health 11.16 Genoptix (Novartis) 11.17 Genmark Diagnostics 11.18 Genomictree 11.19 HTG Molecular Diagnostics 11.20 Invitae 11.21 LabCorp 11.22 Myriad Genetics 11.23 Nanostring 11.24 Neogenomics 11.25 NSTG 11.26 Nuvera Biosciences 11.27 Orion Genomics 11.28 Pathway Genomics 12 Future Forecast 12.1 Molecular Diagnostics in Cancer Testing Market Forecast by Regions 12.1.1 Global Molecular Diagnostics in Cancer Testing Sales Forecast by Regions 2019-2025 12.1.2 Global Molecular Diagnostics in Cancer Testing Revenue Forecast by Regions 2019-2025 12.2 Molecular Diagnostics in Cancer Testing Market Forecast by Product 12.2.1 Global Molecular Diagnostics in Cancer Testing Sales Forecast by Product 2019-2025 12.2.2 Global Molecular Diagnostics in Cancer Testing Revenue Forecast by Product 2019-2025 12.3 Molecular Diagnostics in Cancer Testing Market Forecast by End User 12.4 North America Molecular Diagnostics in Cancer Testing Forecast 12.5 Europe Molecular Diagnostics in Cancer Testing Forecast 12.6 Asia Pacific Molecular Diagnostics in Cancer Testing Forecast 12.7 Central & South America Molecular Diagnostics in Cancer Testing Forecast 12.8 Middle East and Africa Molecular Diagnostics in Cancer Testing Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Molecular Diagnostics in Cancer Testing Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer